Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing

BMC Biotechnology

Volumn 12, Issue , 2012, Pages

  Everaert, Bert R ^a,b,c   Bergwerf, Irene ^a   De Vocht, Nathalie ^a   Ponsaerts, Peter ^a   Van Der Linden, Annemie ^a   Timmermans, Jean Pierre ^a   Vrints, Christiaan J ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Laboratory of Cell Biology and Histology   (Belgium)

Author keywords

Bioluminescence; BMSC; Confocal endomicroscopy; Homing; Stem cell

Indexed keywords

BIOLUMINESCENCE IMAGING; BMSC; CARDIO-VASCULAR DISEASE; CELL TRAPPING; CONFOCAL ENDOMICROSCOPY; HOMING; IN-VIVO; IN-VIVO IMAGING; ISCHEMIC TISSUES; MOUSE MODELS; MULTI-MODAL; PERIPHERAL TISSUE; REPORTER GENE; RESPIRATORY FAILURE; STEM CELL THERAPY; STROMAL CELLS;

BIOLUMINESCENCE; FLUORESCENCE MICROSCOPY; GENE THERAPY; IMAGING TECHNIQUES; PHOSPHORESCENCE; STEM CELLS; TISSUE;

CYTOLOGY;

CYCLOSPORIN A; ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE;

ANIMAL CELL; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENCE IMAGING; BONE MARROW DERIVED STROMAL CELL TRANSPLANTATION; CELL HOMING; CELL SURVIVAL; CONFOCAL MICROSCOPY; DEATH; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; FOLLOW UP; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DEVICE; LUNG CIRCULATION; LUNG INFARCTION; MALE; MICROPROBE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PERIPHERAL ISCHEMIA; REPORTER GENE; RESPIRATORY FAILURE; SAFETY; STROMA CELL;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GENES, REPORTER; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; ISCHEMIA; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 84870298401     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-12-93     Document Type: Article

References (23)

1. Ankrum J, Karp JM. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 2010, 16:203-209. 10.1016/j.molmed.2010.02.005, 2881950, 20335067.
2. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
3. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSC): controversies, myths, and changing paradigms. Mol Ther 2009, 17:939-946. 10.1038/mt.2009.62, 2835176, 19337235.
4. Wu JC, Abraham MR, Kraitchman DL. Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 2010, 51(Suppl 1):128S-136S. 3076100, 20395348.
5. Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res 2009, 104:398-402. 10.1161/CIRCRESAHA.108.187724, 19096027.
6. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868. 10.1161/01.CIR.0000084828.50310.6A, 12900340.
7. Merx MW, Zernecke A, Liehn EA, et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol 2005, 100:208-216. 10.1007/s00395-005-0516-9, 15690102.
8. Bergwerf I, De Vocht N, Tambuyzer B, et al. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol 2009, 9:1. 10.1186/1472-6750-9-1, 2630974, 19128466.
9. Ronsyn MW, Daans J, Spaepen G, et al. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol 2007, 7:90. 10.1186/1472-6750-7-90, 2225398, 18078525.
10. Swijnenburg RJ, Schrepfer S, Govaert JA, et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A 2008, 105:12991-12996. 10.1073/pnas.0805802105, 2529073, 18728188.
11. Swanger, Neuhuber B, Himes BT, Bakshi A, Fischer I. Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant 2005, 14:775-786. 10.3727/000000005783982594, 16454352.
12. Zangi L, Margalit R, Reich-Zeliger S, et al. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 2009, 27:2865-2874. 10.1002/stem.217, 19750539.
13. Liew A, O'Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 2012, 3:28. 10.1186/scrt119, 22846185.
14. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20. 10.1159/000047856, 11340257.
15. Daldrup-Link H, E Rudelius M, et al. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur J Nucl Med Mol Imaging 2004, 31:1312-1321.
16. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc 2007, 39:573-576. 10.1016/j.transproceed.2006.12.019, 17362785.
17. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007, 116:I38-I45.
18. Kang WJ, Kang HJ, Kim HS, Chung JK, Lee MC, Lee DS. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med 2006, 47:1295-1301.
19. Reekmans KP, Praet J, De Vocht N, et al. Clinical potential of intravenous neural stem cell delivery for treatment of neuro-inflammatory disease in mice?. Cell Transplant 2010, 20:851-869.
20. Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 2009, 110:1189-1197. 10.3171/2008.9.JNS08158, 2889620, 19301973.
21. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95:9-20. 10.1161/01.RES.0000135902.99383.6f, 15242981.
22. Song H, Song BW, Cha MJ, Choi IG, Hwang KC. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther 2010, 10:309-319. 10.1517/14712590903455997, 20132054.
23. Liu H, Liu S, Li Y, et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One 2012, 7:e34608. 10.1371/journal.pone.0034608, 3325280, 22511954.